Vitamine Nicotinamide Alleviate Chronic, Progressive Multiple Sclerosis
Filed in archive Drugs, Vaccines and Therapeutics on September 27, 2006
Researchers in the Neurobiology Program at Children's Hospital Boston have found in animal studies that nicotinamide injections may prevent further nerve-fiber damage in patients on the chronic progressive phase of multiple sclerosis. Their findings appear in a cover article in the September 20 Journal of Neuroscience.
...mice with [experimental autoimmune encephalitis] who received daily nicotinamide injections under their skin had a delayed onset of neurologic disability, and the severity of their deficits was reduced for at least eight weeks after treatment. The greater the dose of nicotinamide, the greater the protective effect
Nicotinamide appears to increase the nicotinamide adenine dinucleotide (NAD) levels in the spinal cord, which protects the axons from degeneration. Nicotinamide is an inexpensive and readily available vitamin, but as the doses that would be required for humans will be much higher than that used in these animal trials, a clinical study will have to be set up to test its safety and efficacy.
[Photo: In mice with MS-like disease, nicotinamide delayed and reduced neurologic disability as indicated by behavioral scores. Source: CHB]

Tags: nicotinamide vitamins multiple+sclerosis neurodegeneration neurology
Vote for Vitamine Nicotinamide Alleviate Chronic, Progressive Multiple Sclerosis:
|
Rating: 7.00 out of 5 vote(s) cast.
|
Most Popular
Best of
Biotech Hubs and Facilities
Biotech/Science Blogs
Corporate and Industrial News
Diagnostics, Methodologies and Instrumentation
Did you know
Drugs, Vaccines and Therapeutics
Energy, Environment and Ecology
Food and Agriculture
Gene Therapy
Genomics, Proteomics and Bioinformatics
Information About
Meetings and Other Events
Microbiology
Misc
Nanomedicine
Other Biotechnology News
Patents and Intellectual Property Rights
Quick introduction
Stem Cells
